Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo

Antioxidants and Redox Signaling

Volumn 21, Issue 1, 2014, Pages 1-16

  Tao, Rong Rong ^a   Wang, Huan ^a   Hong, Ling Juan ^a   Huang, Ji Yun ^a   Lu, Ying Mei ^b   Liao, Mei Hua ^a   Ye, Wei Feng ^a,c   Lu, Nan Nan ^a   Zhu, Dan Yan ^a   Huang, Qian ^d   Fukunaga, Kohji ^e   Lou, Yi Jia ^a   Shoji, Ikuo ^f   Wilcox, Christopher Stuart ^g   Lai, En Yin ^d,g   Han, Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

^c CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e TOHOKU UNIVERSITY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; E3 UBIQUITIN LIGASE E6 ASSOCIATED PROTEIN; LENTIVIRUS VECTOR; PEROXIREDOXIN 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; PEROXIREDOXIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; STRESS; UBIQUITINATION; ANIMAL; CEREBRAL ARTERY DISEASE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEOMICS;

ANIMALS; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; PEROXIREDOXINS; PROTEOMICS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84902166111     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5381     Document Type: Article

References (51)

1. Aracena P, Tang W, Hamilton SL, and Hidalgo C. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal 7: 870-881, 2005.
2. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, and Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 468: 557-561, 2010.
3. Braeuninger S and Kleinschnitz C. Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med 1: 8, 2009.
4. Brunet Simioni M, De Thonel A, Hammann A, Joly AL, Bossis G, Fourmaux E, Bouchot A, Landry J, Piechaczyk M, and Garrido C. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene 28: 3332-3344, 2009.
5. Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2: 396-409, 2005.
6. Chae HZ, Kang SW, and Rhee SG. Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300: 219-226, 1999.
7. Chae HZ, Oubrahim H, Park JW, Rhee SG, and Chock PB. Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators. Antioxid Redox Signal 16: 506-523, 2012.
8. Coe H, Bedard K, Groenendyk J, Jung J, and Michalak M. Endoplasmic reticulum stress in the absence of calnexin. Cell Stress Chaperones 13: 497-507, 2008.
9. del Zoppo GJ. . The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci 1207: 46-49, 2010.
10. Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid Redox Signal 15: 831-844, 2011.
11. Gan Y, Ji X, Hu X, Luo Y, Zhang L, Li P, Liu X, Yan F, Vosler P, Gao Y, Stetler RA, and Chen J. Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive prodeath signaling pathway. Antioxid Redox Signal 17: 719-732, 2012.
12. Geraerts M, Eggermont K, Hernandez-Acosta P, Garcia-Verdugo JM, Baekelandt V, and Debyser Z. Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Hum Gene Ther 17: 635-650, 2006.
13. Girouard H, Park L, Anrather J, Zhou P, and Iadecola C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler Thromb Vasc Biol 27: 303-309, 2007.
14. Guo X, Yamada S, Tanimoto A, Ding Y, Wang KY, Shimajiri S, Murata Y, Kimura S, Tasaki T, Nabeshima A, Watanabe T, Kohno K, and Sasaguri Y. Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice. Antioxid Redox Signal 17: 1362-1375, 2012.
15. Han F, Ali Raie A, Shioda N, Qin ZH, and Fukunaga K. Accumulation of beta-amyloid in the brain microvessels accompanies increased hyperphosphorylated tau proteins following microsphere embolism in aged rats. Neuroscience 153: 414-427, 2008.
16. Han F, Chen YX, Lu YM, Huang JY, Zhang GS, Tao RR, Ji YL, Liao MH, Fukunaga K, and Qin ZH. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res 51: 124-135, 2011.
17. Han F, Shirasaki Y, and Fukunaga K. Microsphere embolisminduced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain. J Neurochem 99: 97-106, 2006.
18. Han F, Tao RR, Zhang GS, Lu YM, Liu LL, Chen YX, Lou YJ, Fukunaga K, and Hong ZH. Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells. J Pineal Res 50: 281-291, 2011.
19. Hu BR, Martone ME, Jones YZ, and Liu CL. Protein aggregation following transient cerebral ischemia. J Neurosci 20: 3191-3199, 2000.
20. Jakobsson J and Lundberg C. Lentiviral vectors for use in the central nervous system. Mol The 13: 484-493, 2006.
21. Kakihana T, Nagata K, and Sitia R. Peroxides and peroxidases in the endoplasmic reticulum: integrating redox homeostasis and oxidative folding. Antioxid Redox Signal 16: 763-771, 2012.
22. Kao WH, Beaudenon SL, Talis AL, Huibregtse JM, and Howley PM. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol 74: 6408-6417, 2000.
23. Kim SY, Kim TJ, and Lee KY. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett 582: 1913-1918, 2008.
24. Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, and Park YM. Human prx1 gene is a target of Nrf2 and is upregulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-554, 2007.
25. Kisucka J, Chauhan AK, Patten IS, Yesilaltay A, Neumann C, Van Etten RA, Krieger M, and Wagner DD. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 103: 598-605, 2008.
26. Leblanc GG, Golanov E, Awad IA, and Young WL. Biology of Vascular Malformations of the Brain NINDS Workshop Collaborators. Biology of vascular malformations of the brain. Stroke 40: e694-e702, 2009.
27. Liu C, Fei E, Wang H, Tao R, Iwata A, Nukina N, Zhou J, and Wang G. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated-synuclein implies lewy body biogenesis. J Biol Chem 282: 14558-14566, 2007.
28. Liu G, Feinstein SI, Wang Y, Dodia C, Fisher D, Yu K, Ho YS, and Fisher AB. Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against oxidative stress in the mouse lung. Free Radic Biol Med 49: 1172-1181, 2010.
29. Liu QB, Liu LL, Lu YM, Tao RR, Huang JY, Han F, and Lou YJ. The induction of reactive oxygen species and loss of mitochondrial Omi/HtrA2 is associated with S-nitrosoglutathione-induced apoptosis in human endothelial cells. Toxicol Appl Pharmacol 244: 374-384, 2010.
30. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, and Reddy PH. Mitochondria-targeted antioxidants protect against amyloidbeta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20: S609-S631, 2010.
31. Mowbray AL, Kang DH, Rhee SG, Kang SW, and Jo H. Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant. J Biol Chem 283: 1622-1627, 2008.
32. Nakamura T and Lipton SA. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Antioxid Redox Signal 14: 1479-1492, 2011.
33. Nasu J, Murakami K, Miyagawa S, Yamashita R, Ichimura T, Wakita T, Hotta H, Miyamura T, Suzuki T, Satoh T, and Shoji I. E6AP ubiquitin ligase mediates ubiquitindependent degradation of peroxiredoxin 1. J Cell Biochem 111: 676-685, 2010.
34. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, and Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003.
35. Pitts A, Dailey K, Newington JT, Chien A, Arseneault R, Cann T, Thompson LM, and Cumming RC. Dithiol based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant hungtington. J Biol Chem 287: 22717-22729, 2012.
36. Quaegebeur A, Segura I, and Carmeliet P. Pericytes: bloodbrain barrier safeguards against neurodegeneration? Neuron 68: 321-323, 2010.
37. Quaegebeur A, Lange C, and Carmeliet P. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 71: 406-424, 2011.
38. Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, Louisot P, and Lunardi J. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 277: 19396-19401, 2002.
39. Rani V, Neumann CA, Shao C, and Tischfield JA. Prdx1 deficiency in mice promotes tissue specific loss of heterozygosity mediated by deficiency in DNA repair and increased oxidative stress. Mutat Res 735: 39-45, 2012.
40. Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, and Gollnick SO. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1a. PLoS One 7: e50394, 2012.
41. Rizzo MT and Leaver HA. Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease. Mol Neurobiol 42: 52-63, 2010.
42. Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, Shani V, and Engelender S. a-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A 108: 18666-186671, 2011.
43. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, and Kashihara N. NAD (P) h oxidase and uncoupled nitric oxide syntase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288: F1144-F1152, 2005.
44. Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, and de Vries HE. Protective effects of peroxiredoxin-1 at the injured blood-brain barrier. Free Radic Biol Med 45: 256-264, 2008.
45. Shioda N, Han F, Moriguchi S, and Fukunaga K. Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J Neurochem 102: 1506-1517, 2007.
46. Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T, Fukuda K, Abe K, Sato S, Fukasawa M, Yamakawa Y, Nishijima M, Moriishi K, Matsuura Y, Wakita T, Suzuki T, Howley PM, Miyamura T, and Shoji I. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 81: 1174-1185, 2007.
47. Sultana R, Perluigi M, Newman SF, Pierce WM, Cini C, Coccia R, and Butterfield DA. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 12: 327-336, 2010.
48. Tan KH, Harrington S, Purcell WM, and Hurst RD. Peroxinitrite mediates nitric oxide-induced blood-brain barrier damage. Neurochem Res 29: 579-587, 2004.
49. Tao RR, Ji YL, Lu YM, Fukunaga K, and Han F. Targeting nitrosative stress for neurovascular protection: new implications in brain diseases. Curr Drug Targets 13: 272-284, 2012.
50. Wilcox CS and Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 60: 418-469, 2008.
51. Zhang GS, Tian Y, Huang JY, Tao RR, Liao MH, Lu YM, Ye WF, Wang R, Fukunaga K, Lou YJ, and Han F. The c-Secretase blocker DAPT reduces the permeability of the blood-brain barrier by decreasing the ubiquitination and degradation of occludin during permanent brain ischemia. CNS Neurosci Ther 19: 53-60, 2012.